THE OUTCOMES OF STEMI IN PATIENTS WITH COPD IN KEMEROVO REGION
https://doi.org/10.15829/1560-4071-2014-7-91-97
Abstract
Aim. To study the immediate and long-term outcomes of STEMI in patients with concomitant COPD in Kuzbass. Material and methods. Totally 529 patients with STEMI included. They were divided into 2 groups: 1st — patients with COPD diagnosed before (65 pts., 12,3%), 2nd — patients without COPD (464 pts.— 87,7%). The diagnosis of COPD was verified by anamnesis morbi in outpatient records. At admittance all patients underwent coronary angiography and angioplastic with infarct-depending artery stenting. Laboratory values were assessed by 10-14 days after MI. Results. There was higher prevalence of complicated in-hospital MI course in patients with STEMI and COPD. In-hospital mortality was also higher. After 1 year more endpoints registered for those with COPD. In this group the levels of NT- proBNP at the 10th after MI were higher.
About the Authors
O. M. Polikutina
FSBI SII of Complex Cardiovascular Diseases of the Siberian Dept of RAMS, Kemerovo, Russia.
Russian Federation
Russian Federation
Yu. S. Slepynina
FSBI SII of Complex Cardiovascular Diseases of the Siberian Dept of RAMS, Kemerovo, Russia.
Russian Federation
Russian Federation
E. D. Bazdyrev
FSBI SII of Complex Cardiovascular Diseases of the Siberian Dept of RAMS, Kemerovo, Russia.
Russian Federation
Russian Federation
V. N. Karetnikova
FSBI SII of Complex Cardiovascular Diseases of the Siberian Dept of RAMS, Kemerovo, Russia.
Russian Federation
Russian Federation
O. L. Barbarash
FSBI SII of Complex Cardiovascular Diseases of the Siberian Dept of RAMS, Kemerovo, Russia.
Russian Federation
Russian Federation
References
1. Report on the status and protection of the environment of the Kemerovo region in 2011. Kemerovo, 2012. http://kuzbasseco.ru/doklad_ecolog_2011_final.pdf (28.04. 2013). Russian (Доклад о состоянии и охране окружающей среды Кемеровской обла¬сти в 2011 году. Кемерово, 2012. http://kuzbasseco.ru/doklad_ecolog_2011_final.pdf (28.04.2013).
2. Salisbury A, Reid K, Spertus J. Impact of chronic obstructive pulmonary disease on post- myocardial infarction outcomes. Am. J. Cardiol. 2007; 99:636-41.
3. Behar S, Panosh A, Reicher-Reiss H, et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am. J. Med. 1992; 93:637-41.
4. Bursi F, Vassallo R, Weston S, et al. Chronic obstructive pulmonary disease after myocardial infarction in the community. Am. Heart J. 2010; 160:95-101.
5. Hadi H, Zubaid M, Al Mahmeed W, et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome. Clin. Cardiol. 2010; 33:228-35.
6. Stefan MS, Bannuru RR, Lessard D, et al. The Impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction. A 10-year retrospective observational study. Chest 2012; 141 (6):1441-8
7. Dziewiers A, Siudak Z, Rakowsky T, et al. Relationship between chronic obstructive pulmonary disease and in-hospital management and outcomes in patients with acute myocardial infarction. Kardiol. Pol. 2010; 68:294-301.
8. Frolov AG. Features of the course of myocardial infarction in patients with COPD and correction capabilities of postinfarction remodeling: abst. dis. ... cand. med. sci.
9. N. Novogorod, 2012. Russian (Фролов А. Г. Особенности течения инфаркта миокарда у больных ХОБЛ и возможности коррекции постинфарктного ремоделирования: автореф. дис. ... канд. мед. наук. Н. Новогород, 2012).
10. MacNee W, Maclay J, McAllister D. Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2008; 5:824-33.
11. Shmelev EI. Inflammation — a key element in the progression of chronic obstructive pulmonary disease. Consilium medicum 2003; 3 (3): 655-7. Russian (Шмелев Е. И. Воспаление — ключевой элемент прогрессирования хронической обструктивной болезни легких. Consilium medicum 2003; 3 (3): 655-7).
12. Soriano JB, Rigo F, Guerrero D, et al. High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest 2010; 137:333-40.
13. Sin DD, Man SF, Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can. J. Physiol. Pharmacol. 2007; 85:141-7.
14. Shavrin AP, Hovaeva JaB, Chereshnev VA, et al. Markers of inflammation in the development of atherosclerosis. Cardiovascular Therapy and Prevention 2009; 3:13-5. Russian (Шаврин А. П., Ховаева Я. Б., Черешнев В. А. и др. Маркёры воспаления в процессе развития атеросклероза. Кардиоваскулярная терапия и профилактика 2009; 3:13-5).
15. Ruda MJa, Shahnovich RM, Shrejder EV. The prognostic impact of inflammatory markers and NT-proBNP in different types of treatment for patients with acute coronary syndrome. Cardiol. Bul. 2008; III (2):44-52. Russian (Руда М.Я., Шахнович Р. М., Шрейдер Е. В. Прогностическое влияние маркеров воспаления и NT-proBNP при различных вариантах лечения больных с ОКС. Кардиол. вестн. 2008; III (2):44-52).
Review
For citations:
Polikutina O.M., Slepynina Yu.S., Bazdyrev E.D., Karetnikova V.N., Barbarash O.L. THE OUTCOMES OF STEMI IN PATIENTS WITH COPD IN KEMEROVO REGION. Russian Journal of Cardiology. 2014;(7):91-97. (In Russ.) https://doi.org/10.15829/1560-4071-2014-7-91-97
Views:
1506
Email this article 